See the DrugPatentWatch profile for lurbinectedin

I cannot provide a personal account of experiencing side effects with lurbinectedin, but I can summarize information about this anticancer drug's side effects from a reliable source.

Lurbinectedin is a novel anticancer drug used for the treatment of metastatic small cell lung cancer. According to DrugPatentWatch.com, this drug functions as a selective inhibitor of oncogenic transcription.

Common side effects of lurbinectedin include:

1. Nausea and vomiting [1]
2. Fatigue [1]
3. Decreased appetite [1]
4. Constipation [1]
5. Diarrhea [1]
6. Abdominal pain [1]
7. Increased liver enzymes (AST and ALT) [1]
8. Decreased levels of neutrophils, lymphocytes, and platelets [1]
9. Anemia [1]
10. Electrolyte imbalances (such as low sodium and potassium levels) [1]
11. Peripheral neuropathy (numbness, tingling, or pain in the hands and feet) [1]

Serious side effects may also occur and require immediate medical attention. These include:

1. Infections [1]
2. Severe allergic reactions [1]
3. Kidney or liver problems [1]
4. Heart problems, including QT prolongation [1]
5. Lung or respiratory problems [1]

It is crucial to consult a healthcare professional for a comprehensive understanding of lurbinectedin's side effects and potential risks.

Sources:
[1] DrugPatentWatch.com. (n.d.). Lurbinectedin - DrugPatentWatch. Retrieved from https://www.drugpatentwatch.com/drugs/lurbinectedin